Comparison of Induction Characteristics of two Anaesthetic Agents: Etomidate-lipuro and Propofol for Day Care Surgery

被引:2
作者
Govardhane, Balasaheb Tukaram [1 ]
Basantwani, Shakuntala Nanikraam [1 ]
Pal, Ajay [2 ]
Magar, Jyoti Sandeep [1 ]
Tendolkar, Bharati Anil [1 ]
机构
[1] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Anaesthesiol, Fourth Floor,Coll Bldg, Bombay 400022, Maharashtra, India
[2] Medanta Medicity, Dept Anaesthesiol, Crit Care, Gurgram, Haryana, India
关键词
Entropy; Etomidate-lipuro; Haemodynamics; Propofol; Side effects;
D O I
10.7860/JCDR/2018/31483.11224
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Induction of anaesthesia is the most critical stage of anaesthesia. Thus, an induction agent with less side effect should be used. Aim: To compare the newer formulation of Etomidate in lipid formulation (Etomidate-lipuro) and propofol-lignocaine admixture in patients undergoing day care gynaecological surgery. Materials and Methods: Hundred ASA I and II patients in the age group 18-60 years, scheduled for dilatation and curettage procedure were randomly allocated to receive either Etomidate-lipuro 0.2 mg/kg or propofol 2 mg/kg. Both groups received intravenous midazolam 0.05 mg/kg and fentanyl 2 mu g/kg as premedication. After induction with the desired agent titrated to Response Entropy (RE) 40, the time to achieve values to 40 (RE 40 time) were measured. Heart Rate (HR), Mean Arterial Pressures (MAP) were recorded at baseline, at induction and every minute for 15 minutes. Incidence of pain at injection site, myoclonus, apnea and thrombophlebitis were observed. Statistical analysis was done using Chi-square test and Student unpaired t-test. Results: Haemodynamic parameters (HR and MAP) were well maintained with etomidate. There was a significant decline in HR and MAP with propofol as compared to etomidate (p<0.001). Onset of anaesthesia (Time to achieve RE 40) was 81.22 +/- 2.79 s and 77.60 +/- 230 s in propofol and Etomidate-lipuro respectively (p<0.001). The incidence of pain was more with propofol-lidocaine admixture (40%) as compared to no pain with etomidate (p<0.05). None of the patients had myoclonus and postoperative thrombophlebitis in our study. Incidence of postoperative nausea was high with etomidate use (22%) than with propofol (14%) but statistically insignificant (p>0.05). None of the patient in our study had vomiting. Incidence of apnoea was higher with propofol (58%) as compared to etomidate (14%) (p<0.001). Conclusion: Etomidate-lipuro can be a valuable induction agent due to its haemodynamic stability and lesser side effect profile for day care surgery.
引用
收藏
页码:UC01 / UC04
页数:4
相关论文
共 19 条
[1]   Hemodynamic Responses to Etomidate in Pediatric Patients with Congenital Cardiac Shunt Lesions [J].
Dhawan, Naresh ;
Chauhan, Sandeep ;
Kothari, Shyam Sunder ;
Kiran, Usha ;
Das, Shambhunath ;
Makhija, Neeti .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (05) :802-807
[2]   Solvent for etomidate may cause pain and adverse effects [J].
Doenicke, AW ;
Roizen, MF ;
Hoernecke, R ;
Lorenz, W ;
Ostwald, P .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (03) :464-466
[3]   Clinical and Molecular Pharmacology of Etomidate [J].
Forman, Stuart A. .
ANESTHESIOLOGY, 2011, 114 (03) :695-707
[4]  
Isitemiz I, 2014, MED SCI MONITOR, V20, P262, DOI 10.12659/MSM.889833
[5]  
Kalogridaki M, 2011, HELL J CARDIOL, V52, P483
[6]   Remifentanil pretreatment reduces myoclonus after etomidate [J].
Kelsaka, E ;
Karakaya, D ;
Sarihasan, B ;
Baris, S .
JOURNAL OF CLINICAL ANESTHESIA, 2006, 18 (02) :83-86
[7]  
Kosarek L, 2011, OCHSNER J, V11, P143
[8]  
Nazemroaya BBE., 2017, ARCH ANESTH CRIT CAR, V3, P283
[9]   Etomidate-®Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine [J].
Nyman, Y. ;
Von Hofsten, K. ;
Palm, C. ;
Eksborg, S. ;
Lonnqvist, P. A. .
BRITISH JOURNAL OF ANAESTHESIA, 2006, 97 (04) :536-539
[10]   Magnesium sulfate versus Lidocaine pretreatment for prevention of pain on etomidate injection: A randomized, double-blinded placebo controlled trial [J].
Safavi, Mohammadreza ;
Honarmand, Azim ;
Sahaf, Ashraf Sadat ;
Sahaf, Seyyed Mohammad ;
Attari, Mohammadali ;
Payandeh, Mahsa ;
Iazdani, Alireza ;
Norian, Nilofarsaddat .
JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2015, 4 (01) :4-8